within Pharmacolibrary.Drugs.V_Various.V09I_TumourDetection.V09IX02_Iobenguane131i;

model Iobenguane131i
  extends Pharmacolibrary.Drugs.ATC.V.V09IX02;

  annotation (Documentation(
info       = "<html><body><table><tr><td>name:</td><td>Iobenguane131i</td></tr><tr><td>ATC code:</td><td>V09IX02</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Iobenguane (131I), also known as 131I-metaiodobenzylguanidine (131I-MIBG), is a radiopharmaceutical agent used primarily for diagnostic imaging and treatment of certain types of neuroendocrine tumors, such as pheochromocytoma and neuroblastoma. It is labeled with radioactive iodine-131 and selectively taken up by adrenergic tissue. 131I-MIBG is currently approved for therapeutic use in metastatic or relapsed high-risk neuroblastoma.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters as reported in adult patients undergoing therapy for neuroendocrine tumors; data from published clinical studies and product information.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial generated model</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Iobenguane131i;
